Related Experiment Video

Updated: Jul 15, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia

Sheila Rydziel1, Lisa Stadmeyer, Stefano Zanotti

  • 1Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.

The Journal of Biological Chemistry
|May 15, 2007
PubMed

Insights

Nephroblastoma overexpressed (Nov) protein inhibits osteoblast differentiation by antagonizing bone morphogenetic protein (BMP) and Wnt signaling pathways, leading to osteopenia in mice.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Protein Function

Background:

  • Nephroblastoma overexpressed (Nov) is a CCN family protein expressed in osteoblasts.
  • Its precise function in osteoblast lineage cells remains unclear.

Purpose of the Study:

  • To investigate the role of Nov in osteoblast differentiation and bone metabolism.
  • To elucidate the molecular mechanisms underlying Nov's function in osteogenesis.

Main Methods:

  • Overexpression of Nov in murine ST-2 stromal and MC3T3 osteoblastic cells using retroviral vectors.
  • Generation and analysis of transgenic mice with Nov overexpression under the human osteocalcin promoter.
  • Assessment of osteoblast differentiation markers (alkaline phosphatase, osteocalcin).
  • Analysis of BMP/Smad and Wnt/beta-catenin signaling pathways using reporter constructs.
  • Glutathione S-transferase pulldown assays to detect protein interactions.

Main Results:

  • Nov overexpression inhibited mineralization, alkaline phosphatase activity, and osteocalcin mRNA levels in osteoblastic cells.
  • Nov antagonized BMP-2-induced Smad 1/5/8 phosphorylation and Wnt-3-induced beta-catenin accumulation.
  • Direct binding of Nov to BMP-2 was confirmed.
  • Nov transgenic mice displayed osteopenia, indicating impaired bone formation.

Conclusions:

  • Nov directly binds BMP-2 and antagonizes both BMP-2 and Wnt signaling pathways.
  • Overexpression of Nov inhibits osteoblastogenesis and leads to osteopenia.
  • Nov plays a critical inhibitory role in bone formation and homeostasis.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...